Jean‐Luc Raoul
About
Jean‐Luc Raoul is a scholar working on Oncology, Hepatology and Pulmonary and Respiratory Medicine.
According to data from OpenAlex, Jean‐Luc Raoul has authored 342 papers receiving a total of 26.4k indexed citations (citations by other indexed papers that have themselves been cited), including 152 papers in Oncology, 134 papers in Hepatology and 107 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jean‐Luc Raoul's work include Hepatocellular Carcinoma Treatment and Prognosis (127 papers), Pancreatic and Hepatic Oncology Research (57 papers) and Neuroendocrine Tumor Research Advances (53 papers). Jean‐Luc Raoul is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (127 papers), Pancreatic and Hepatic Oncology Research (57 papers) and Neuroendocrine Tumor Research Advances (53 papers). Jean‐Luc Raoul collaborates with scholars based in France, United States and Belgium. Jean‐Luc Raoul's co-authors include Alejandro Forner, Vincenzo Mazzaferro, Fabio Piscaglia, Peter R. Galle, Josep M. Llovet, Valérie Vilgrain, Peter Schirmacher, Olivier Bouché, Marc Ychou and Y. Bécouarn and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
In The Last Decade
Jean‐Luc Raoul
332 papers receiving 25.9k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Jean‐Luc Raoul France | 56 | 12.1k | 11.6k | 9.4k | 5.9k | 5.8k | 342 | 26.4k | ||
| Al B. Benson United States | 94 | 18.9k 1.6× | 5.8k 0.5× | 5.1k 0.5× | 8.7k 1.5× | 8.7k 1.5× | 492 | 31.0k | ||
| Michel Ducreux France | 91 | 26.0k 2.2× | 8.7k 0.8× | 8.2k 0.9× | 11.8k 2.0× | 10.7k 1.8× | 628 | 38.9k | ||
| Takuji Okusaka Japan | 65 | 10.7k 0.9× | 5.4k 0.5× | 5.3k 0.6× | 6.3k 1.1× | 4.7k 0.8× | 534 | 19.6k | ||
| David M. Nagorney United States | 81 | 11.3k 0.9× | 7.9k 0.7× | 7.0k 0.7× | 12.0k 2.0× | 7.6k 1.3× | 377 | 23.9k | ||
| Vincenzo Mazzaferro Italy | 74 | 7.8k 0.6× | 26.0k 2.2× | 15.9k 1.7× | 10.8k 1.8× | 5.2k 0.9× | 364 | 39.1k | ||
| Andrew X. Zhu United States | 82 | 13.0k 1.1× | 18.2k 1.6× | 9.0k 1.0× | 8.9k 1.5× | 7.5k 1.3× | 418 | 36.2k | ||
| Eddie K. Abdalla United States | 71 | 13.8k 1.1× | 11.5k 1.0× | 8.4k 0.9× | 8.8k 1.5× | 4.7k 0.8× | 145 | 22.2k | ||
| Bruno Sangro Spain | 77 | 7.6k 0.6× | 16.2k 1.4× | 8.4k 0.9× | 4.8k 0.8× | 4.2k 0.7× | 416 | 26.0k | ||
| Alan P. Venook United States | 67 | 9.8k 0.8× | 5.2k 0.4× | 3.5k 0.4× | 3.5k 0.6× | 3.8k 0.7× | 365 | 17.5k | ||
| Chris Verslype Belgium | 51 | 7.3k 0.6× | 6.1k 0.5× | 3.7k 0.4× | 3.8k 0.6× | 3.8k 0.7× | 338 | 15.4k |
Countries citing papers authored by Jean‐Luc Raoul
Since
Specialization
Citations
This map shows the geographic impact of Jean‐Luc Raoul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Luc Raoul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Luc Raoul more than expected).
Fields of papers citing papers by Jean‐Luc Raoul
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Jean‐Luc Raoul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Luc Raoul. The network helps show where Jean‐Luc Raoul may publish in the future.
Co-authorship network of co-authors of Jean‐Luc Raoul
This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐Luc Raoul. A scholar is included among the top collaborators of Jean‐Luc Raoul based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐Luc Raoul. Jean‐Luc Raoul is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Seegers, Valérie, Guillaume Rousseau, Ke Zhou, et al.. (2023). COVID-19 Infection despite Previous Vaccination in Cancer Patients and Healthcare Workers: Results from a French Prospective Multicenter Cohort (PAPESCO-19). Cancers. 15(19). 4777–4777.
2.
Seegers, Valérie, Guillaume Rousseau, Ke Zhou, et al.. (2022). COVID-19 Vaccination Campaign in Cancer Patients and Healthcare Workers-Results from a French Prospective Multicenter Cohort (PAPESCO-19). Cancers. 14(22). 5547–5547.
3.
Raoul, Jean‐Luc, et al.. (2022). Prolonged response on olaparib maintenance in metastatic pancreatic acinar cell carcinoma associated with a germline BRCA 2 mutation, revealed by severe panniculitis. SHILAP Revista de lepidopterología. 10(12). e6718–e6718.
4.
Zhou, Ke, Audrey Blanc-Lapierre, Valérie Seegers, et al.. (2021). Anosmia but Not Ageusia as a COVID-19-Related Symptom among Cancer Patients—First Results from the PAPESCO-19 Cohort Study. Cancers. 13(14). 3389–3389.
5.
Thibaudeau, Emilie, et al.. (2021). Acute respiratory distress syndrome (ARDS) after pressurized intraperitoneal aerosol chemotherapy with oxaliplatin: a case report. SHILAP Revista de lepidopterología. 6(4). 167–170.
6.
Pernot, Simon, Olivier Pellerin, Pascal Artru, et al.. (2020). Intra-arterial hepatic beads loaded with irinotecan (DEBIRI) with mFOLFOX6 in unresectable liver metastases from colorectal cancer: a Phase 2 study. British Journal of Cancer. 123(4). 518–524.
7.
Mollévi, Caroline, Sophie Gourgou, Marie‐Pierre Galais, et al.. (2017). Health-related quality of life results from the PRODIGE 5/ACCORD 17 randomised trial of FOLFOX versus fluorouracil–cisplatin regimen in oesophageal cancer. European Journal of Cancer. 84. 239–249.
8.
Raoul, Jean‐Luc, Xavier Adhoute, Marine Gilabert, & Julien Edeline. (2016). How to assess the efficacy or failure of targeted therapy: Deciding when to stop sorafenib in hepatocellular carcinoma. World Journal of Hepatology. 8(35). 1541–1541.
9.
Adhoute, Xavier, Guillaume Pénaranda, Jean‐Luc Raoul, et al.. (2015). Prognosis of advanced hepatocellular carcinoma. European Journal of Gastroenterology & Hepatology. 28(4). 433–440.
10.
Adhoute, Xavier, Guillaume Pénaranda, Jean‐Luc Raoul, et al.. (2014). Retreatment with TACE: The ABCR SCORE, an aid to the decision-making process. Journal of Hepatology. 62(4). 855–862.
11.
Vinik, Aaron I., Eric Van Cutsem, Patricia Niccoli, et al.. (2012). Progression-Free Survival (PFS) by Blinded Independent Central Review (BICR) and Updated Overall Survival (OS) of Sunitinib versus Placebo for Patients with Progressive, Unresectable, Well Differentiated Pancreatic Neuroendocrine Tumor (NET). Pancreas. 41(2). 350–350.
12.
Lenoir, Laurence, Julien Edeline, Y. Rolland, et al.. (2012). Usefulness and pitfalls of MAA SPECT/CT in identifying digestive extrahepatic uptake when planning liver radioembolization. European Journal of Nuclear Medicine and Molecular Imaging. 39(5). 872–880.
13.
Raoul, Jean‐Luc, Jordi Bruix, Tim F. Greten, et al.. (2012). Relationship between baseline hepatic status and outcome, and effect of sorafenib on liver function: SHARP trial subanalyses. Journal of Hepatology. 56(5). 1080–1088.
14.
Garin, Étienne, Laurence Lenoir, Yan Rolland, et al.. (2012). Dosimetry Based on 99mTc-Macroaggregated Albumin SPECT/CT Accurately Predicts Tumor Response and Survival in Hepatocellular Carcinoma Patients Treated with 90Y-Loaded Glass Microspheres: Preliminary Results. Journal of Nuclear Medicine. 53(2). 255–263.
15.
Park, Joong‐Won, Richard S. Finn, Mark Karwal, et al.. (2011). Phase II, Open-Label Study of Brivanib as First-Line Therapy in Patients with Advanced Hepatocellular Carcinoma. Clinical Cancer Research. 17(7). 1973–1983.
16.
Raoul, Jean‐Luc, Julien Edeline, Marc Pracht, et al.. (2011). Traitement des carcinomes hépatocellulaires par injection intra-artérielle de radio-isotopes. Cancer/Radiothérapie. 15(1). 64–68.
17.
Valle, Juan W., Patricia Niccoli, Jean‐Luc Raoul, et al.. (2011). Updated Overall Survival Data From a Phase III Study of Sunitinib Vs. Placebo in Patients With Advanced, Unresectable Pancreatic Neuroendocrine Tumour (NET). European Journal of Cancer. 47.
18.
Raymond, Éric, Ivan Borbath, Jean‐Luc Raoul, et al.. (2009). Phase III, Randomized, Double-blind Trial of Sunitinib Versus Placebo in Patients With Progressive, Well-differentiated Pancreatic Islet Cell Tumours. Annals of Oncology. 20. 11–11.
19.
Peeters, Marc, Jean‐Luc Raoul, Jean‐Luc Van Laethem, et al.. (2005). Cetuximab in combination with irinotecan/5-fluorouracil (5-FU)/folinic acid (FA) (FOLFIRI) in the first-line treatment of metastatic colorectal cancer (mCRC). Ghent University Academic Bibliography (Ghent University).
20.
Siproudhis, Laurent, Alain Ropert, Josette Lucas, et al.. (1992). Defecatory disorders, anorectal and pelvic floor dysfunction: a polygamy?. International Journal of Colorectal Disease. 7(2). 102–107.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Al B. Benson Breakdown of academic impact, for papers by Michel Ducreux Breakdown of academic impact, for papers by Takuji Okusaka Breakdown of academic impact, for papers by David M. Nagorney Breakdown of academic impact, for papers by Vincenzo Mazzaferro Breakdown of academic impact, for papers by Andrew X. Zhu Breakdown of academic impact, for papers by Eddie K. Abdalla Breakdown of academic impact, for papers by Bruno Sangro Breakdown of academic impact, for papers by Alan P. Venook Breakdown of academic impact, for papers by Chris Verslype